DS
ORGO icon

David Shaw’s Organogenesis Holdings ORGO Stock Holding History

David Shaw’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.02M Buy
2,888,313
+590,339
+26% +$1.44M ﹤0.01% 2140
2026
Q1 		$5.45M Buy
2,297,974
+309,495
+16% +$1.07M ﹤0.01% 2112
2025
Q4 		$10.3M Buy
1,988,479
+1,476,843
+289% +$7.16M 0.01% 1725
2025
Q3 		$2.16M Sell
511,636
-101,423
-17% -$471K ﹤0.01% 2916
2025
Q2 		$2.24M Sell
613,059
-271,229
-31% -$1.01M ﹤0.01% 2654
2025
Q1 		$3.82M Buy
884,288
+146,845
+20% +$593K ﹤0.01% 2105
2024
Q4 		$2.36M Sell
737,443
-672
-0.1% -$2.25K ﹤0.01% 2598
2024
Q3 		$2.11M Sell
738,115
-3,818
-0.5% -$10.7K ﹤0.01% 2670
2024
Q2 		$2.08M Buy
741,933
+109,189
+17% +$293K ﹤0.01% 2624
2024
Q1 		$1.8M Sell
632,744
-334,128
-35% -$1.14M ﹤0.01% 2719
2023
Q4 		$3.95M Sell
966,872
-119,346
-11% -$334K ﹤0.01% 2100
2023
Q3 		$3.45M Sell
1,086,218
-184,747
-15% -$587K ﹤0.01% 2146
2023
Q2 		$4.22M Sell
1,270,965
-69,878
-5% -$207K ﹤0.01% 1999
2023
Q1 		$2.86M Buy
1,340,843
+909,003
+210% +$2.25M ﹤0.01% 2415
2022
Q4 		$1.16M Buy
431,840
+237,062
+122% +$692K ﹤0.01% 3331
2022
Q3 		$631K Buy
194,778
+43,523
+29% +$197K ﹤0.01% 3892
2022
Q2 		$738K Buy
151,255
+87,490
+137% +$539K ﹤0.01% 3825
2022
Q1 		$486K Sell
63,765
-12,740
-17% -$98.6K ﹤0.01% 4386
2021
Q4 		$707K Sell
76,505
-56,812
-43% -$603K ﹤0.01% 4183
2021
Q3 		$1.9M Buy
133,317
+88,723
+199% +$1.38M ﹤0.01% 3080
2021
Q2 		$741K Buy
+44,594
New +$831K ﹤0.01% 3784

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

David Shaw's ORGO Position: Q2 2026 in Review

David Shaw increased its Organogenesis Holdings (ORGO) stake by 26% in Q2 2026, buying an estimated $1.44M and bringing the position to 2,888,313 shares worth $7.02M. The position accounts for ﹤0.01% of the portfolio, ranked #2140.

David Shaw first reported a position in ORGO in Q2 2021 and has held it in 21 quarters since. The position peaked at $10.3M in Q4 2025. 135 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

  • David Shaw held 2,888,313 shares of Organogenesis Holdings worth $7.02M as of Q2 2026.
  • David Shaw bought 590,339 Organogenesis Holdings shares in Q2 2026, an estimated $1.44M.
  • Organogenesis Holdings made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #2140 holding.
  • David Shaw first reported a position in Organogenesis Holdings in Q2 2021 and has held it in 21 quarters since.
  • David Shaw's Organogenesis Holdings position peaked at $10.3M in Q4 2025.
  • 135 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.